Devices › Device types
FDA product code OBJ · class 2 · Cardiovascular
Catheter, ultrasound, intravascular: medical device reports filed with FDA
7,935 reports carry this product code, 2004–2026; 11 brands with a page.
- 7,935
- reports with this product code
- 0% of all MAUDE reports
- 1,202
- reports, 12 months to August 2026
- 725 in the 12 months before
- 85%
- classified as malfunction
- 62.3% across all reports
- 1%
- classified as death, as reported
- 0.9% across all reports
Product code OBJ is FDA's classification for "Catheter, ultrasound, intravascular" (cardiovascular panel), a class 2 device. 7,935 medical device reports carry this product code, 0% of the MAUDE database, from June 2004 to August 2026.
1,202 reports arrived in the 12 months to August 2026, up 66% from 725 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (85%), injury (13.7%) and death (1%). 11 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| OptiCross | 1,948 | 136 | 0.9% | 87.2% |
| OptiCross HD | 1,700 | 617 | 0.6% | 87.7% |
| iLab Ultrasound Imaging System | 913 | 85 | 0.2% | 98.5% |
| ViewFlex Xtra ICE Catheter | 396 | 66 | 1.2% | 86.8% |
| OptiCross? 6 HD | 360 | 144 | 2% | 86.6% |
| OptiCross 18 | 312 | 31 | 0% | 88.9% |
| Soundstar | 168 | 29 | 0% | 82.2% |
| Acuson | 85 | 0 | 0.4% | 92.9% |
| Acist | 13 | 14 | 10.6% | 14.9% |
| Decanav Electrophysiology Catheter | 1 | 4 | 3.3% | 32.7% |
| Dexcom G6 Continuous Glucose Monitoring System | 1 | 61,710 | 0% | 99.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Boston Scientific - Fremont Ce | 829 | 10.4% |
| Volcano | 573 | 7.2% |
| Boston Scientific - Fremont Sud | 526 | 6.6% |
| Biosense Webster | 493 | 6.2% |
| Boston Scientific - Costa Rica Coyol | 490 | 6.2% |
| Siemens Medical Solutions USA | 336 | 4.2% |
| St Jude Medical | 207 | 2.6% |
| Dexcom | 52 | 0.7% |
| Biosense Webster Irwindale | 48 | 0.6% |
| St Jude Medical Costa Rica Ltda | 18 | 0.2% |
| Philips Ultrasound | 3 | 0% |
| Abbott Laboratories | 2 | 0% |
| Abbott Diabetes Care | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Retraction problem | 1,163 | 14.7% |
| Entrapment of device | 1,056 | 13.3% |
| Poor quality image | 958 | 12.1% |
| No display/image | 753 | 9.5% |
| Detachment of device or device componentpart of the device came off | 674 | 8.5% |
| Air/gas in device | 432 | 5.4% |
| Material deformation | 409 | 5.2% |
| Fracturea broken bone | 373 | 4.7% |
| Material separation | 357 | 4.5% |
| Material twisted/bent | 351 | 4.4% |
| Material integrity problema problem with the device material | 303 | 3.8% |
| Failure to advance | 269 | 3.4% |
| Nonstandard device | 241 | 3% |
| Difficult to flush | 217 | 2.7% |
| Physical resistance/sticking | 168 | 2.1% |
| Unable to obtain readings | 157 | 2% |
| Patient device interaction problem | 124 | 1.6% |
| Detachment of device component | 108 | 1.4% |
| Breakthe device broke | 107 | 1.3% |
| Device displays incorrect message | 103 | 1.3% |
Questions about catheter, ultrasound, intravascular reports
What is product code OBJ?
FDA's classification code for "Catheter, ultrasound, intravascular", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
7,935 reports through August 2026, 1,202 of them in the latest 12 months.
Which brands appear most often?
OptiCross (1,948), OptiCross HD (1,700), iLab Ultrasound Imaging System (913), ViewFlex Xtra ICE Catheter (396) and OptiCross? 6 HD (360). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.